Practice Resources | Assessment Tools
©MASCC, Multinational Association for Supportive Care in Cancer™ • All rights reserved worldwide.
The MASCC/ESMO Antiemetic Guidelines have been updated as of March, 2016. The revised guidelines, published in Annals of Oncology (vol 27;suppl 5:v119-v133, 2016) are based on the Copenhagen Consensus Conference on Antiemetic Therapy, June 2015, and have been endorsed by both MASCC and ESMO. See the MASCC/ESMO Antiemetic Guidelines for the full text of the Guidelines, supporting Consensus Recommendation Papers, and the updated Guideline Slide Set.
A major effort of the Mucositis Study Group of MASCC/ISOO has been a comprehensive review of the literature related to mucositis and the development of evidence-based clinical practice guidelines. The first set of MASCC/ISOO Mucositis Guidelines was published in the journal Cancer in 2004. The first update of these guidelines was described in publications in 2006 and 2007. The most recent update is now available here at the MASCC website: Mucositis Guidelines. This includes a summary paper published in Cancer 2014 and available via open access. In addition, a set of publications in Supportive Care in Cancer describes detailed results for different categories of interventions for mucositis. A summary of the guidelines is also posted.
MASCC Endorsed Guideline Partnerships
Endorsement of externally generated Practice Guidelines, those not created through MASCC, requires final approval by MASCC’s Executive Committee. Guidelines are first reviewed by the most relevant Study Group, which makes a recommendation to the Guideline Committee. On the basis of comments from the Study Group and its own expertise, the Guideline Committee may make a recommendation to the Executive Committee. Endorsement means that the guidelines are consistent with the best evidence available and are suitable for use in practice. For more information, see the MASCC Guideline Policy .
The following external guidelines have been endorsed by MASCC:
- Guideline for the Prevention and Treatment of Anticipatory Nausea and Vomiting Due to Chemotherapy in Pediatric Cancer Patients
- Acute AINV Guideline for Pediatric Cancer Patients
- International Pediatric Fever and Neutropenia Guideline
>> View these partner guidelines
For more information contact:
Åge Schultz, DVM, PhD - MASCC Executive Director
Herredsvejen 2, DK-3400 Hillerød Denmark
Phone: +45 4820 7022; Fax: +45 4821 7022